Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

van der Heijde, Désirée; Dijkmans, Ben; Geusens, Piet; Sieper, Joachim; DeWoody, Kimberly; Williamson, Paul; Braun, Jürgen

doi:10.1002/art.20852

Public

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

Shared by NobleBlocks on Feb 1, 2005 • 12:00 AM UTC

Authors:

Désirée van der Heijde

Ben Dijkmans

Piet Geusens

Abstract

Abstract Objective The signs and symptoms of ankylosing spondylitis (AS) respond inadequately to nonsteroidal antiinflammatory drugs, corticosteroids, and disease‐modifying antirheumatic drugs in quite a number of patients. Tumor necrosis factor inhibitors have demonstrated success in reducing AS di...

Discussions